HomepageMedicineIDEAYA Names Stu Dorman as New Chief Commercial Officer Medicine IDEAYA Names Stu Dorman as New Chief Commercial Officer admin Posted on November 22, 2024 Dorman previously served as head of Gilead Sciences’ U.S. Oncology Unit. LEAVE A RESPONSE Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. admin View all posts Post navigation Previous PostLitter Robot 4 Review 2024: How It Measured Up in My Multi-Cat Home Next PostHow to Plan a Family Heritage Trip You Might Also Like Medicine Invivyd Seeks EUA for Monoclonal Antibody Designed to Prevent COVID-19 in Immunocompromised Individuals admin January 4, 2024 Medicine Zongertinib Demonstrates High Objective Response Rate in Previously Treated Advanced Non-Small Cell Lung Cancer admin September 11, 2024 Medicine Pharma Pulse 7/3/24: What to Know About New and Future ALZ Drugs, Bridging the Gap Between Innovation and Implementation & more admin July 6, 2024 Medicine The Power of AI: Personalized Medicine and Predictive Analytics admin December 30, 2024
Medicine Invivyd Seeks EUA for Monoclonal Antibody Designed to Prevent COVID-19 in Immunocompromised Individuals admin January 4, 2024
Medicine Zongertinib Demonstrates High Objective Response Rate in Previously Treated Advanced Non-Small Cell Lung Cancer admin September 11, 2024
Medicine Pharma Pulse 7/3/24: What to Know About New and Future ALZ Drugs, Bridging the Gap Between Innovation and Implementation & more admin July 6, 2024